<?xml version="1.0" encoding="UTF-8"?>
<p>Treatment with OA increased the expression of occlusion junction proteins, such as ZO-1, ocludine and claudin-1 (KANG et al., 2015), that act in maintaining intestinal integrity [
 <xref rid="B50-molecules-25-05430" ref-type="bibr">50</xref>]. Furthermore, treatment with OA inhibited the expression of TNF-α, IL-1β and IL-17 and the activation of NF-κB and MAPKs. The results suggest that OA can improve the inflammation present in colitis, inhibiting Th17 cell differentiation and increasing Treg cell differentiation [
 <xref rid="B92-molecules-25-05430" ref-type="bibr">92</xref>].
</p>
